Provided by Tiger Trade Technology Pte. Ltd.

Xtant Medical

0.4800
+0.00992.11%
Post-market: 0.4670-0.0130-2.71%19:38 EDT
Volume:129.48K
Turnover:61.15K
Market Cap:67.20M
PE:43.62
High:0.4825
Open:0.4660
Low:0.4600
Close:0.4701
52wk High:0.9500
52wk Low:0.4380
Shares:140.00M
Float Shares:38.07M
Volume Ratio:0.69
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0110
EPS(LYR):0.0300
ROE:3.95%
ROA:2.37%
PB:1.38
PE(LYR):16.00

Loading ...

Adagio Medical submits FDA PMA application for vCLAS ventricular ablation system

Reuters
·
May 21

Xtant Medical Balances New Growth Bets With Near-Term Pain

TIPRANKS
·
May 20

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 15

Maxim Group Sticks to Their Buy Rating for Xtant Medical Holdings (XTNT)

TIPRANKS
·
May 14

Adagio Medical releases investor presentation on vCLAS ventricular tachycardia ablation system

Reuters
·
May 14

Xtant Medical Holdings Price Target Maintained With a $1.00/Share by BTIG

Dow Jones
·
May 14

Xtant Medical Q1 revenue falls less than expected, outlook raised

Reuters
·
May 13

Xtant Medical Hldgs Q1 EPS $(0.02), Inline, Sales $20.884M Beat $20.164M Estimate

Benzinga
·
May 13

Xtant Medical Outlook FY Revenue USD 101-105 Million

THOMSON REUTERS
·
May 13

Xtant Medical Q1 Revenue USD 20.9 Million

THOMSON REUTERS
·
May 13

Adagio Medical Q1 FY26 net loss narrows to $7 million; R&D expense falls to $2.7 million

Reuters
·
May 12

Xtant Medical to report Q1 results, host conference call May 13

Reuters
·
May 07

3 Promising Penny Stocks With Market Caps Under $200M

Simply Wall St.
·
May 01

Adagio Medical to present at BofA Securities 2026 Health Care Conference

Reuters
·
Apr 29

Adagio Medical FULCRUM-VT trial meets endpoints for vCLAS ventricular ablation system

Reuters
·
Apr 26

Adagio Medical announces annual shareholder meeting

Reuters
·
Apr 21

Xtant Medical resumed with a Buy at Maxim

TIPRANKS
·
Apr 20

Adagio Medical ULTA technology featured in scientific sessions at Heart Rhythm 2026 conference

Reuters
·
Apr 16

Xtant Medical Expands Portfolio with HEMOBLAST Distribution Deal

TIPRANKS
·
Apr 13

Xtant Medical wins exclusive US distribution rights for Dilon hemostat HEMOBLAST Bellows

Reuters
·
Apr 13